A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
Status:
Terminated
Trial end date:
2017-10-03
Target enrollment:
Participant gender:
Summary
A phase 2 study to find out if the drug ruxolitinib Phosphate Cream is safe and has
beneficial effects in people who have alopecia areata (partial or complete hair loss) when
applied to the skin.